期刊文献+

MUC1肿瘤抗原表位PDTRP基因免疫诱导的体内外抗瘤效应 被引量:1

Anti-Tumor Efficacy Induced by Antibodized PDTRP Gene Immunization
下载PDF
导出
摘要 目的:构建MUC1肿瘤抗原表位γlneo-PDTRP质粒,基因免疫诱导机体产生有效的体内外抗瘤效应。方法:用 Insight Ⅱ将PDTRP抗原表位与MUC1分子模拟,构建含PDTRP的抗原化抗体表达质粒γlneo-PDTRP,体外转染检测表达。 用该质粒基因免疫小鼠,免疫后ELISA动态检测血清中抗PDTRP抗体的产生及特异性细胞免疫应答;以4T1-PDTRP肿瘤细 胞攻击经γlneo-PDTRP免疫小鼠,观察免疫保护效应。结果:三串联肿瘤抗原表位PDTRPDTRPDTRP模拟了MUC1核心序列 的空间结构;构建γlneo-PDTRP质粒并在体外转染表达,基因免疫小鼠诱导出特异性抗PDTRP体液和细胞免疫应答,免疫小 鼠对4T1-PDTRP肿瘤细胞的攻击具有显著的体内保护效应。结论:MUC1肿瘤抗原表位PDTRP可模拟MUC1核心序列的天 然构象,γlneo-PDTRP基因免疫在体外诱导特异性的体液和细胞免疫应答,体内诱导对机体的免疫保护效应。 Objective: To study the anti-tumor efficacy induced by antibodized tumor epitope PDTRP gene immunization. Methods: Three copies of tumor associate gene PDTRP from MUCI tandem repeats were designed and mimicked the conformation of MUCI by Insight Ⅱ . The γlneo-PDTRP plasmid was further constructed, in which the PDTRP target gene was inserted into CDR3 of the γ1 -neo vector. The specific humoral and cellular immune responses towards to PDTRP were detected after intraspleen immunized Balb/c mice with 'ylneo-PDTRP. And the immune protection assay was also done to observe whether the mice immunized with γlneo-PDTRP could prolong the survival after tumor challenge. Results: The conformation of three copies of PDTRP mimicked the conformation of MUCI tandem repeats. The expression of γlneo-PDTRP could be detected after in vitro transfect. The specific antibody against PDTRP epitope could be induced and increase to a higher titer after intraspleen injection with a γlneo-PDTRP plasmid. And the specific proliferation and cytotox-ic function of lymphocyte were also increased. There is a significant survival from mice immunized with γlneo-PDTRP a-gainst the 4T1-PDTRP tumor challenge. Conclusions: Gene immunization with γlneo-PDTRP could elicit both humoral and cellular tumor specific immune response and had the protective effect.
出处 《中国肿瘤生物治疗杂志》 CAS CSCD 2004年第3期170-174,共5页 Chinese Journal of Cancer Biotherapy
基金 上海-联合利华研究与发展基金资助课题(2010)国家自然科学基金面上项目(30170867)国家重点基础研究发展计划(2001CB10006)资助课题
关键词 体内 表位 肿瘤抗原 基因免疫 诱导 抗瘤效应 细胞免疫应答 核心序列 体外转染 质粒 MUC1 γlneo-PDTRP gene immunization immune protection
  • 相关文献

参考文献10

  • 1Jerome KR, Barnd DL, Bendt KM, et al. Cytotoxic T-lymphocytes derived from patients with breast adenocarcinoma recognize an epitope present on the protein core of a mucin molecule preferentially expressed by malignant cells[J]. Cancer Res, 1991, 51(11): 2
  • 2G erloni M, Lo D, Ballou WR, et al. Immunological memory after somatic transgene immunization is positively affected by priming with GM-CSF and does not require bone marrow-derived dendritic cells[J]. EurJ Immunol, 1998, 28(6): 1832-1838.
  • 3DekkerJ, Rossen JW, BullerHA, etal. TheMUC family: Anobituary[J]. Trends Biochem Sci, 2002, 27(3): 126-131.
  • 4Xiong SD, Gerloni M, Zanetti M, et al. In vivo role of B lymphocytes in somatic transgene immunization[J]. Proc Natl Acad Sci,1997, 94(12): 6352-6357.
  • 5Taylor-Papadimitriou J, Burchell J, Miles DW, et al. MUC1 and cancer[J]. Biochim Biophys Acta, 1999, 1455(2-3):301-313.
  • 6Kosmas C, Maraveyas A, Gooden CS, et al. Anti-chelate antibodies after intraperitoneal yttrium-90-labeled monoclonal antibody immunoconjugates for ovarian cancer therapy [ J ]. J Nucl Med,1995, 36(5): 746-753.
  • 7Riethmuller G, Schneider-Gadicke E, Schlimok G, et al. Randomised trial of monoclonal antibody of adjuvant therapy of resected Dukes'C colorectal cacinoma [ J ]. Lancet, 1994, 343 ( 8907 ):1177-1183.
  • 8Garcia-Viloca M, Gao J, Karplus M, et al. How enzymes work:analysis by modern rate theory and computer simulations[J]. Science, 2004 (5655), 303:186-195.
  • 9Wong CF, McCammon AJ. Protein simulation and drug design [J]. Adv Protein Chem, 2003, 66: 87-121.
  • 10Gerloni M, Rizzi M, Castiglioni P, et al. T cell immunity using transgenic B lymphocytes [ J ]. PNAS, 2004, 101 ( 11 ): 3892-3897.

同被引文献7

  • 1Rosenberg SA. Cancer vaccines based on the identification of genes encoding cancer regression antigens[J]. Immunol Today, 1997, 18: 175-182.
  • 2Overwijk WW, Tsung A, Irvine KR, et al. gp100/pmel 17 is a murine tumor rejection antigen: Induction of "self"-reactive, tumoricidal T cells using high-affinity, altered peptide ligand[J]. J Exp Med, 1998, 188(2): 277-286.
  • 3Gerloni M, Xiong S, Mukerjee S, et al. Functional cooperation between T helper cell determinants[J]. Proc Natl Acad Sci U S A, 2000, 97: 13269 -13274.
  • 4Hartmann TB, Bazhin AV, Schadendorf D, et al. SEREX identification of new tumor antigens linked to melanoma-associated retinopathy[J]. Int J Cancer, 2005, 114(1): 88-93.
  • 5Benlalam H, Linard B, Guilloux Y, et al. Identification of five new HLA-B·3501-restricted epitopes derived from common melanoma-associated antigens, spontaneously recognized by tumorⅠnfiltrating lymphocytes[J]. J Immunol, 2003,171(11): 6283-6289.
  • 6Zhai Y, Yang JC, Spiess P, et al. Cloning and characterization of the genes encoding the murine homologues of the melanoma antigens MART1 and gp100[J]. J Immunother, 1997, 20: 15-25.
  • 7Gerloni M, Rizzi M, Castiglioni P, et al. T cell immunity using transgenic B lymphocytes[J]. Proc Natl Acad Sci U S A, 2004, 101: 3892-3897.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部